JFG
MDGL icon

Jefferies Financial Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jefferies Financial Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$21.2K – 1730
2024
Q3 		$21.2K Buy
+100
New +$25.6K ﹤0.01% 1371
2023
Q1 		– Sell
-7,700
Closed -$2.23M – 1840
2022
Q4 		$2.23M Buy
+7,700
New +$753K 0.02% 620

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Financial Group's MDGL Position: Q1 2026 in Review

Jefferies Financial Group reduced its Madrigal Pharmaceuticals (MDGL) stake by 8.7% in Q1 2026, selling an estimated $95.6K and leaving 2,100 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #890.

Jefferies Financial Group first reported a position in MDGL in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.34M in Q4 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Jefferies Financial Group held 2,100 shares of Madrigal Pharmaceuticals worth $1.1M as of Q1 2026.
  • Jefferies Financial Group sold 200 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $95.6K.
  • Madrigal Pharmaceuticals made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #890 holding.
  • Jefferies Financial Group first reported a position in Madrigal Pharmaceuticals in Q1 2023 and has held it in 6 quarters since.
  • Jefferies Financial Group's Madrigal Pharmaceuticals position peaked at $1.34M in Q4 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.